OptimizeRx (OPRX) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25% |
| Dec 31, 2025 | 20.75% |
| Sep 30, 2025 | 21.24% |
| Jun 30, 2025 | 22.35% |
| Mar 31, 2025 | 21.66% |
| Dec 31, 2024 | 21.13% |
| Sep 30, 2024 | 22.71% |
| Jun 30, 2024 | 23.62% |
| Mar 31, 2024 | 44.51% |
| Dec 31, 2023 | 46.97% |
| Sep 30, 2023 | 46.50% |
| Jun 30, 2023 | 48.94% |
| Mar 31, 2023 | 78.54% |
| Dec 31, 2022 | 82.55% |
| Sep 30, 2022 | 84.55% |
| Jun 30, 2022 | 85.16% |
| Mar 31, 2022 | 79.37% |
| Dec 31, 2021 | 75.85% |
| Sep 30, 2021 | 73.61% |
| Jun 30, 2021 | 72.53% |
| Mar 31, 2021 | 70.14% |
| Dec 31, 2020 | 41.08% |
| Sep 30, 2020 | 38.26% |
| Jun 30, 2020 | 56.04% |
| Mar 31, 2020 | 56.97% |
| Dec 31, 2019 | 57.63% |
| Sep 30, 2019 | 53.33% |
| Jun 30, 2019 | 54.36% |
| Mar 31, 2019 | 33.40% |
| Dec 31, 2018 | 61.73% |
| Sep 30, 2018 | 52.79% |
| Jun 30, 2018 | 54.69% |
| Mar 31, 2018 | 37.49% |
| Dec 31, 2017 | 34.66% |
| Sep 30, 2017 | 35.31% |
| Jun 30, 2017 | 36.00% |
| Mar 31, 2017 | 38.04% |
| Dec 31, 2016 | 37.51% |
| Sep 30, 2016 | 33.30% |
| Jun 30, 2016 | 44.39% |
| Dec 31, 2015 | 36.40% |